1 Min Read
April 3 (Reuters) - Cardiome Pharma Corp:
* Cardiome Pharma Corp - Cardiome’s partner Steadymed Receives favorable ruling in its USPTO inter partes review Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.